Van Eck Associates Corp Pfizer Inc Transaction History

Van Eck Associates Corp

$64.4 Billion
Q1 2024

A detailed history of Van Eck Associates Corp transactions in Pfizer Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 15,813,328 shares of PFE stock, worth $442 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

15,813,328

Previous 12,984,150 21.79%

Holding current value

$442 Million

Previous $374 Million 17.39%

% of portfolio

0.68%

Previous 0.68%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$25.89 - $29.73 $73.2 Million - $84.1 Million	2,829,178 Added 21.79%	15,813,328 $439 Million
Q4 2023 Feb 05, 2024	BUY	$26.13 - $33.94 $85.3 Million - $111 Million	3,265,276 Added 33.6%	12,984,150 $374 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $72.9 Million - $85.3 Million	2,273,275 Added 30.53%	9,718,874 $322 Million
Q2 2023 Aug 03, 2023	BUY	$36.12 - $41.79 $130 Million - $151 Million	3,601,529 Added 93.69%	7,445,599 $273 Million
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $91.7 Million - $119 Million	2,326,950 Added 153.38%	3,844,070 $157 Million

Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $44,338 - $57,879	1,062 Added 0.07%	1,517,120 $77.7 Million
Q3 2022 Oct 27, 2022	BUY	$43.76 - $53.42 $9.1 Million - $11.1 Million	207,989 Added 15.9%	1,516,058 $66.3 Million
Q2 2022 Aug 03, 2022	BUY	$46.53 - $55.17 $39.7 Million - $47 Million	852,451 Added 187.1%	1,308,069 $68.6 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $1.44 Million - $1.78 Million	-31,474 Reduced 6.46%	455,618 $23.6 Million
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $102 Million - $152 Million	-2,476,151 Reduced 83.56%	487,092 $28.8 Million
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $73.7 Million - $94.7 Million	-1,878,344 Reduced 38.8%	2,963,243 $127 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $6.28 Million - $7.11 Million	174,809 Added 3.75%	4,841,587 $190 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $41.9 Million - $47.3 Million	1,251,532 Added 36.65%	4,666,778 $169 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $1.36 Million - $1.73 Million	40,676 Added 1.21%	3,415,246 $126 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $5.62 Million - $6.59 Million	176,988 Added 5.54%	3,374,570 $124 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $10.9 Million - $13.2 Million	360,262 Added 12.7%	3,197,582 $105 Million
Q1 2020 May 12, 2020	BUY	$27.03 - $38.62 $2.38 Million - $3.4 Million	88,099 Added 3.2%	2,837,320 $92.6 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $53.9 Million - $61.2 Million	1,638,466 Added 147.51%	2,749,221 $108 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $7.09 Million - $9.19 Million	218,235 Added 24.45%	1,110,755 $39.9 Million
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $277,904 - $312,022	7,515 Added 0.85%	892,520 $38.7 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $2.68 Million - $2.94 Million	-71,378 Reduced 7.46%	885,005 $37.6 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $19.1 Million - $21.8 Million	-496,151 Reduced 34.16%	956,383 $41.7 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $1.68 Million - $2.03 Million	-48,621 Reduced 3.24%	1,452,534 $64 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $5.33 Million - $5.68 Million	161,589 Added 12.06%	1,501,155 $54.5 Million
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $1.22 Million - $1.41 Million	38,198 Added 2.94%	1,339,566 $47.5 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $1.96 Million - $2.08 Million	-58,889 Reduced 4.33%	1,301,368 $47.1 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $14.3 Million - $15.7 Million	460,062 Added 51.11%	1,360,257 $48.6 Million
Q2 2017 Aug 11, 2017	BUY	N/A	900,195	900,195 $30.2 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Pfizer Inc Transaction History